Bacolod begins preparing for mass vaccination drive vs COVID-19 | Inquirer News

Bacolod begins preparing for mass vaccination drive vs COVID-19

/ 04:02 PM January 21, 2021

BACOLOD CITY –– This city has started preparations for its mass vaccination drive against the coronavirus disease (COVID-19) that could begin as early as next month, according to City Administrator Em Ang.

The Bacolod CoVac (COVID-19 Vaccination) Council held a meeting with the city’s barangay captains at the Bacolod Government Center on Tuesday to discuss preparations for 22 vaccination centers.

Ang said Bacolod was expected to get a share of the national government-purchased Sinovac vaccine, and the Pfizer vaccine from the World Health Organization.

Article continues after this advertisement

The 650,000 doses of AstraZeneca vaccines purchased by Bacolod City are expected to arrive in the third quarter of this year, Ang said.

The doses, he said, would cover 325,000 Bacolod residents.

LZB
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: Bacolod City, Coronavirus, COVID-19, Philippine news updates, Regions

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.